Literature DB >> 9716178

Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

S Gansauge1, A K Nussler, H G Beger, F Gansauge.   

Abstract

Nitric oxide (NO) is a messenger molecule with various biological activities including DNA damage. In the present study, we examined the influence of endogenously produced NO on human pancreatic cell lines. In response to cytokine stimulation (tumor necrosis factor alpha, IFN-gamma, and interleukin 1beta), human pancreatic carcinoma cell lines expressed the inducible NO synthase that synthesizes NO, detectable as nitrate and nitrite in the culture supernatants. Endogenously produced NO induced apoptosis in all of the tested pancreatic carcinoma cell lines. In cell cycle analysis, endogenous production of NO revealed a G1-arrest in all of the tested cell lines. This G1-arrest was blockable by addition of NG-monomethyl-L-arginine. These data indicate that NO induces a G1-arrest followed by apoptosis in pancreatic carcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716178

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  The dual role of TLR3 in metastatic cell line.

Authors:  Tanja Matijevic; Jasminka Pavelic
Journal:  Clin Exp Metastasis       Date:  2011-07-07       Impact factor: 5.150

2.  The roles of nitric oxide synthase and eIF2alpha kinases in regulation of cell cycle upon UVB-irradiation.

Authors:  Lei Wang; Yan Liu; Shiyong Wu
Journal:  Cell Cycle       Date:  2010-01-05       Impact factor: 4.534

3.  A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.

Authors:  Paolo Monti; Federica Marchesi; Michele Reni; Alessia Mercalli; Valeria Sordi; Alessandro Zerbi; Giampaolo Balzano; Valerio Di Carlo; Paola Allavena; Lorenzo Piemonti
Journal:  Virchows Arch       Date:  2004-07-17       Impact factor: 4.064

4.  Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.

Authors:  Hans-U Kasper; Hella Wolf; Uta Drebber; Helmut-K Wolf; Michael-A Kern
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

5.  Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells.

Authors:  Abhijit G Banerjee; Velliyur K Gopalakrishnan; Jamboor K Vishwanatha
Journal:  Mol Cell Biochem       Date:  2007-07-17       Impact factor: 3.396

6.  Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer.

Authors:  G Kong; E K Kim; W S Kim; Y W Lee; J K Lee; S W Paik; J C Rhee; K W Choi; K T Lee
Journal:  Int J Pancreatol       Date:  2001

7.  Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach.

Authors:  Yanfen Ma; Jian Hu; Ning Zhang; Xinran Dong; Ying Li; Bo Yang; Weidong Tian; Xiaoqin Wang
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

Review 8.  The dual role of iNOS in cancer.

Authors:  Federica Vannini; Khosrow Kashfi; Niharika Nath
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

9.  Staphylococcal entertotoxins of the enterotoxin gene cluster (egcSEs) induce nitrous oxide- and cytokine dependent tumor cell apoptosis in a broad panel of human tumor cells.

Authors:  David S Terman; A Serier; O Dauwalder; C Badiou; A Dutour; D Thomas; V Brun; J Bienvenu; J Etienne; F Vandenesch; G Lina
Journal:  Front Cell Infect Microbiol       Date:  2013-08-13       Impact factor: 5.293

10.  Exogenous Nitric Oxide Suppresses in Vivo X-ray-Induced Targeted and Non-Targeted Effects in Zebrafish Embryos.

Authors:  E Y Kong; W K Yeung; T K Y Chan; S H Cheng; K N Yu
Journal:  Int J Mol Sci       Date:  2016-08-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.